A new government analysis revealed that despite a previous warning, CMS failed to take steps to ensure that Medicare Part D does not also pay for drugs that should be covered under the Part A hospice benefit; with studies of antidepressants’ safety and efficacy only following patients for a few years and with more people taking antidepressants for longer periods of time, health professionals are concerned that some people taking the drugs for extended periods shouldn’t be and are thus subjecting themselves to side effects and potential health risks; Medicaid advocates in Nebraska have filed a lawsuit to try and force the state to implement Medicaid expansion no later than November 17, 2019.
A new government analysis revealed that despite a previous warning, CMS failed to take steps to ensure that Medicare Part D does not also pay for drugs that should be covered under the Part A hospice benefit. This resulted in $161 million in duplicate payments in 2016. According to STAT News, duplicate payments were pointed out in 2009 by a 2012 report issued by HHS’ Office of the Inspector General (OIG). In the new analysis, the OIG found that Part D paid $422.7 million for 6.7 million prescriptions for beneficiaries who received hospice care. Hospice organizations should have paid for the drugs and hospices or beneficiaries should have paid for the remaining $262 million in Part D total cost.
With studies of antidepressants’ safety and efficacy only following patients for a few years and with more people taking antidepressants for longer periods of time, health professionals are concerned that some people taking the drugs for extended periods shouldn’t be and are thus subjecting themselves to side effects and potential health risks. According to The Wall Street Journal, some studies have suggested some serious potential risks, including one meta-analysis that found people who used antidepressants had a 14% higher risk of heart attacks and strokes and a 33% increased risk of death.
Medicaid advocates in Nebraska have filed a lawsuit to try and force the state to implement Medicaid expansion no later than November 17, 2019, reported The Hill. According to the lawsuit, the state will miss out on approximately $149 million in federal funding by delaying implementation until October 1, 2020. The suit also says that beginning expansion in November this year will allow federal funds to pay for 93% of the cost of expansion. Voters in the state approved a ballot measure last November that would expand coverage to approximately 94,000 residents in the state. State officials have said they need time to implement expansion methodically and that 2020 implementation would allow them to do so.
Shaping Dermatology's Future by Increasing Access, Data, and Advocacy
March 7th 2025Thy N. Huynh, MD, FAAD, Bruce A. Brod, MHCI, MD, FAAD, and Melissa Piliang, MD, FAAD, discussed expanding access to pediatric dermatology, dermatology data aggregation, and advocacy for Medicare physician payment reform, respectively.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Eliminating Enhanced PTCs Would Have Cascading Economic Impacts, Report Estimates
March 6th 2025Enhanced premium tax credits (PTCs) have made marketplace health insurance more affordable, and eliminating them could have sweeping impacts on consumers and the health care industry, according to a new report.
Read More
Addressing Health Care Disparities Using a Health Plan Quality Measures Index
February 26th 2025The Health Insurance Disparities Index allows stakeholders to assess progress in addressing health care disparities using publicly available, validated, reported health plan quality metrics results.
Read More